Usual and Rare Abdominal Location of Giant Cell Arteritis Diagnosed and Follow-up With 18F-FDG PET/CT.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Apr 2021
01 Apr 2021
Historique:
pubmed:
26
11
2020
medline:
15
4
2021
entrez:
25
11
2020
Statut:
ppublish
Résumé
Giant cell arteritis is not an uncommon disease, and its extension is furthermore finely assessed with new-generation PET/CT system. 18F-FDG PET/CT is increasingly used in case of large-vessel vasculitis for optimal diagnosis, activity monitoring (even when treated with interleukin 6 receptor inhibitor), and evaluation damage progression. We reported the case of a 61-year-old woman with common giant cell arteritis pattern on 18F-FDG PET/CT (aorta and large arteries) and uptakes in all aorta branches, mainly impressive and uncommon in the abdomen. After 2 years of therapeutic optimization including IV tocilizumab and monitoring with 18F-FDG PET/CT, a complete metabolical response was assessed.
Identifiants
pubmed: 33234925
pii: 00003072-202104000-00035
doi: 10.1097/RLU.0000000000003415
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e218-e220Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Prieto-González S, Depetris M, García-martínez A, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. Ann Rheum Dis . 2014;73:1388–1392.
Slart RHJA; Writing group; Reviewer group; Members of EANM Cardiovascular; Members of EANM Infection & Inflammation; Members of Committees, SNMMI Cardiovascular; Members of Council, PET Interest Group; Members of ASNC; EANM Committee Coordinator. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging . 2018;45:1250–1269.
Flaus A, Granjon D, Habouzit V, et al. Unusual and diffuse hypermetabolism in routine F-FDG PET/CT of the supra-aortic vessels in biopsy-positive giant cell arteritis. Clin Nucl Med . 2018;43:336–337.
Ahmadi Bidakhvidi N, Goffin K, Van Laere K, et al. 18 F-FDG PET in giant cell arteritis. Clin Nucl Med . 2020;45:170–171.
Lensen KD, Comans EF, Voskuyl AE, et al. Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18 F-FDG-PET/CT. Biomed Res Int . 2015;2015:914692.
Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med . 2017;377:317–328.
Vitiello G, Orsi Battaglini C, Carli G, et al. Tocilizumab in giant cell arteritis: a real-life retrospective study. Angiology . 2018;69:763–769.
Banerjee S, Quinn KA, Gribbons KB, et al. Effect of treatment on imaging, clinical, and serologic assessments of disease activity in large-vessel vasculitis. J Rheumatol . 2020;47:99–107.